Daily non-political popular news in brief.

UCF nanoparticle offers promise for treating glaucoma

The UCF created nanoparticle can safely get past the blood-brain barrier, making it a nontoxic tool in treatment.

Read more »

Keywords: ucf, nanoparticle, offers, promise, treating, glaucoma, offer

« Previous | Next »

Similar news on "UCF nanoparticle offers promise for treating glaucoma":

1. Experimental MS drug shows promise, offers new window on disease
   02-13-2008 · EurekAlert!
   A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial led by scientists at University of California-San Francisco.
   Similar news · Read more »
   
2. Targeted nanoparticles incorporating siRNA offer promise for cancer treatment
   05-20-2007 · EurekAlert!
   The use of targeted nanoparticles offers promising techniques for cancer treatment. Researchers in the laboratory of Mark E. Davis at the California Institute of Technology have been using small interfering RNA (siRNA), sometimes known as silencing RNA, to "silence" specific genes that are implicated in certain malignancies. The results of this research are being presented this week at the NSTI Nanotech 2007 Conference in Santa Clara, Calif.
   Similar news · Read more »
   
3. Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer
   05-08-2007 · EurekAlert!
   A combination of molecular-targeted therapy and hormonal therapy may be the most promising area of research for those seeking an effective treatment for ovarian cancer, according to a new review in the International Journal of Gynecological Cancer.
   Similar news · Read more »
   
4. Commonly used drug offers promise for premature babies
   05-17-2007 · EurekAlert!
   Scientists have found evidence that the cox-2 inhibitor celecoxib, a common pain reliever used to treat arthritis, may offer a new way to reduce the risk of the most common cause of brain damage in babies born prematurely.
   Similar news · Read more »
   
5. Genetic breakthrough offers promise in tackling kidney tumors
   01-10-2008 · EurekAlert!
   Early tests show promising results for a new treatment for tuberous sclerosis, which can cause tumors in organs throughout the body. The UK study is led by Cardiff University's Institute of Medical Genetics, which was the first to identify the genes linked to the disease.
   Similar news · Read more »
   
6. New drug shows promise for treating epileptic seizures
   04-05-2007 · EurekAlert!
   A new study appearing in the latest issue of Epilepsia shows that a new drug called Eslicarbazepine (ESL) shows promise as a treatment for epilepsy patients whose symptoms remain uncontrolled with existing medications. A once-daily dose was shown to be most effective, offering patients added convenience as current treatments can involve several doses per day.
   Similar news · Read more »
   
7. Innovative device to treat brain cancer shows promise in early studies
   05-29-2007 · EurekAlert!
   New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields -- called Tumor-Treating Fields -- more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme, the most common and aggressive type of malignant brain tumor.
   Similar news · Read more »
   
8. Medication does not appear to offer benefit for certain heart attack patients undergoing PCI
   01-02-2007 · EurekAlert!
   Use of the drug pexelizumab immediately before and for 24 hours after stent placement or angioplasty for certain heart attack patients did not have any significant treatment effect compared to placebo, according to a study in the Jan. 3 issue of JAMA. The medication had shown promise in preliminary studies.
   Similar news · Read more »
   
9. Drug/intervention combinations offer benefit in severe CVD
   03-26-2007 · EurekAlert!
   While millions of Americans suffer from severe cardiac dysfunction, only about 3,000 heart transplants are possible each year. In the meantime, doctors are trying to identify new combinations of medicines and interventions that will increase survival rates among this high-risk population. Research presented today at the American College of Cardiology's 56th Annual Scientific Session offers new insight into the most effective therapies for patients with severe left ventricular dysfunction, cardiogenic shock and perioperative hypertension.
   Similar news · Read more »
   
10. Promising drug combination may help those with ocular melanoma that has spread
    09-04-2007 · EurekAlert!
    A combination of two drugs shows promise in treating a rare and therapy-resistant type of melanoma that originates in the eye and spreads to other organs, according to a new study led by Duke University Comprehensive Cancer Center researchers.
    Similar news · Read more »